Merit Medical Systems (NASDAQ:MMSI) is scheduled to release its earnings data after the market closes on Wednesday, February 28th. Analysts expect Merit Medical Systems to post earnings of $0.32 per share for the quarter.
Shares of Merit Medical Systems (NASDAQ MMSI) opened at $45.50 on Wednesday. The company has a quick ratio of 1.43, a current ratio of 2.78 and a debt-to-equity ratio of 0.39. Merit Medical Systems has a fifty-two week low of $27.65 and a fifty-two week high of $48.10. The company has a market cap of $2,294.09, a P/E ratio of 74.92, a P/E/G ratio of 2.65 and a beta of 1.29.
In other news, Director Franklin J. Miller sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, December 29th. The shares were sold at an average price of $43.93, for a total transaction of $439,300.00. Following the sale, the director now owns 21,244 shares in the company, valued at $933,248.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kent W. Stanger sold 9,082 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $44.90, for a total transaction of $407,781.80. The disclosure for this sale can be found here. Insiders have sold 32,000 shares of company stock worth $1,416,379 in the last 90 days. 5.00% of the stock is owned by company insiders.
A number of research firms recently commented on MMSI. Zacks Investment Research downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Thursday, January 25th. ValuEngine downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Friday, December 1st. BidaskClub upgraded shares of Merit Medical Systems from a “sell” rating to a “hold” rating in a report on Thursday, January 18th. SunTrust Banks set a $47.00 target price on shares of Merit Medical Systems and gave the stock a “buy” rating in a report on Thursday, November 16th. Finally, Canaccord Genuity boosted their target price on shares of Merit Medical Systems from $45.00 to $47.50 and gave the stock a “buy” rating in a report on Thursday, October 26th. Four analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $43.77.
COPYRIGHT VIOLATION NOTICE: “Merit Medical Systems (MMSI) Scheduled to Post Quarterly Earnings on Wednesday” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/21/merit-medical-systems-mmsi-scheduled-to-post-quarterly-earnings-on-wednesday.html.
Merit Medical Systems Company Profile
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.